Related Experiment Video
Updated: Oct 2, 2026
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
Modulation of neuronal MAO activity, 5-HT uptake and imipramine binding by endogenous substances in dog cerebrospinal
Abstract:
Addition of small amounts of dog cerebrospinal fluid (CSF) inhibited both type A and type B monoamine oxidase (MAO) in dog brain mitochondria. The inhibition was competitive with 5-HT as substrate, but non-competitive with beta-phenylethylamine as substrate. Tricyclic antidepressants also exhibited competitive inhibition with type A MAO, but were non-competitive with type B MAO. The endogenous materials in CSF activate [3H]-imipramine specific, dose-dependent binding in dog brain preparations. The maximum number of binding sites (Bmax) increased, but the dissociation constant (Kd) was altered significantly in the presence of CSF. Addition of CSF induced a marked activation of uncompetitive [14C]-5-HT uptake in dog brain preparations. Moreover, there were reversibilities of the inhibition of MAO activity or of the activation of imipramine binding and 5-HT uptake by CSF substance after dilution experiment. These results indicate the possible presence of an endogenous psychotic drug-like substance in CSF.
Insights
Dog cerebrospinal fluid (CSF) contains a substance that inhibits monoamine oxidase (MAO) and affects neurotransmitter uptake and binding. This endogenous compound in CSF may possess drug-like properties, influencing brain activity.
Area of Science:
- Neurochemistry
- Pharmacology
- Neuroscience
Background:
- Monoamine oxidase (MAO) enzymes are crucial for neurotransmitter metabolism.
- Cerebrospinal fluid (CSF) contains various endogenous compounds that can modulate brain function.
- Understanding CSF's neurochemical components is vital for neurological research.
Purpose of the Study:
- To investigate the effects of dog cerebrospinal fluid (CSF) on monoamine oxidase (MAO) activity.
- To examine CSF's influence on neurotransmitter transporter binding and uptake.
- To determine if CSF contains endogenous psychoactive substances.
Main Methods:
- Assessed MAO inhibition by CSF using 5-HT and beta-phenylethylamine as substrates.
- Analyzed [3H]-imipramine binding kinetics (Bmax and Kd) in dog brain preparations with and without CSF.
- Measured [14C]-5-HT uptake in dog brain preparations following CSF addition.
Main Results:
- CSF inhibited both MAO-A and MAO-B; inhibition patterns varied with substrate.
- CSF increased the maximum number of binding sites (Bmax) for [3H]-imipramine, altering dissociation constant (Kd).
- CSF markedly activated uncompetitive [14C]-5-HT uptake, with effects reversible upon dilution.
Conclusions:
- Dog CSF contains endogenous substances that modulate MAO activity, imipramine binding, and serotonin uptake.
- These findings suggest the presence of a novel, potentially psychoactive, drug-like substance within CSF.
- Further research is warranted to isolate and characterize this endogenous CSF compound.
More Related Videos
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021